CAS 2231068-83-8

Mavezelimab

CAS: 2231068-83-8

A humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II.

Ref: 3D-CLA1597

Favezelimab

CAS: 2231068-83-8

Favezelimab (MK-4280) blocks LAG-3/MHC II interaction, restoring T-cell function, studied in colorectal cancer research and with PD-L1 inhibitors.

Reinheit: 95% - 96.9% (SDS-PAGE); 96.9% (SEC-HPLC)

Farbe und Form: Liquid

Ref: TM-T82414